drugset / Trial / NCT00998699

Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well Controlled Type 1 Diabetes

NCT00998699

RandomizedParallel-groupDouble-blindTreatment

Summary

The study hypothesis is that XOMA 052 may inhibit beta-cell destruction and enhance beta-cell regeneration. The purpose of this study is to assess the effects of XOMA 052 on beta-cell function and insulin production.

Timeline

Start
2010-02
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator gevokizumab Monoclonal antibody Subcutaneous